Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture

October 29, 2024 updated by: Samuli Aspinen, Töölö Hospital

A Randomized Controlled Trial Comparing Traditional Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture: a Study Protocol

Trial purpose is to research the outcome comparing traditional physiotherapy vs telerehabilitation after volar plating of distal radius fracture.

Patients with distal radius fracture that meet the operative criteria set by the Finnish Current Care guidelines are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo operative treatment and traditional physiotherapy vs telerehabilitation.

Baseline data is collected preoperatively and patients are followed at 1, 3 and 12 months after enrollment. The primary end-point is 3 months and the primary outcome is the Patient-Rated Wrist Evaluation (PRWE).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Uusimaa
      • Helsinki, Uusimaa, Finland, 00029
        • Recruiting
        • Division of Musculosceletal and Plastic Surgery, Hand Surgery Unit, Helsinki University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Distal radius fracture, which applies the surgical requirements
  • age between 18 to 65 years
  • Non concomitant injuries including ligament injuries and distal ulna fractures, however ulnar styloid avulsion is accepted
  • No significant comorbidities
  • No previous problems with the examined hand
  • Ability to understand Finnish fluently

Exclusion Criteria:

  • High energy or multiple injuries
  • Open fractures
  • Injury of both upper extremities
  • Other operative injury on the same side
  • Rheumatoid arthritis of other inflammatory joint disease
  • Heavy smoker (over 20 cigarettes per day)
  • Disease of medication slowing ossification
  • Alcohol or drug abuse
  • Psychiatric disorder with poor treatment balance
  • Neurological disorder which affects the function of the injured extremity
  • Fixation material other than a volar locking plate
  • Fracture fixation is not stable enough to start rehabilitation after 14 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telerehabilitation
The telerehabilitation group will start the physiotherapy guided by the digital care pathway postoperatively. The pathway includes videos, photos, animations and written material for rehabilitation of the operated hand. The same weightbearing instructions and mobilization exercises are shown in the videos and photos as are instructed in the physiotherapist appointment in the traditional physiotherapy group.
Telerehabilitation program
Active Comparator: Traditional Physiotherapy
The traditional physiotherapy group will attend appointment with the physiotherapist at two-week and five week timepoints. After this, this group can attend additional physiotherapist appointments if seen necessary by the physiotherapist or the surgeon.
Guided rehabilitation program with physiotherapist appointments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Rated Wrist Evaluation (PRWE)
Time Frame: 12 months
The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists two subscales: Pain and Function (0=best possible outcome, 10=worst possible outcome)
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global improvement
Time Frame: 12 months
Global rating to treatment effect will be evaluated by question: "How would you rate the function of your hand compared to the situation before the treatment?". The options are in 5-step Likert scale from (-2) Much worse to (+2) Much better
12 months
Grip strength
Time Frame: 12 months
Grip strength is measured with a dynamometer in kg as the mean of three measurements. It will be numbered in kg and percentage of the unaffected side
12 months
Wrist range of motion (ROM)
Time Frame: 12 months
Wrist ROM is measured on both wrists with a handheld goniometer in degrees.
12 months
Quick Disabilities of the arm, shoulder, and hand
Time Frame: 12 months
The QuickDASH is self-reported questionnaire and shortened version of DASH outcome measure to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb in 11 dimensions in 1-5 scale (1=best possible outcome, 5=worst possible outcome)
12 months
Pain (Visual Analogue Scale)
Time Frame: 12 months
The VAS is derived by health care professional question of pain in scale 0 to 10 (0=no pain, 10=worst possible pain).
12 months
Adverse events
Time Frame: 12 months
Incidence of adverse events (i.e. non-union, fracture, reoperation, infection, iatrogenic tendon/nerve/arterial injury, complex regional pain syndrome, traumatic arthritis) is recorded and compared between study groups.
12 months
Cost-utility analysis
Time Frame: 12 months
Quality-adjusted life years/months measured as a change in EQ-5D
12 months
Patient-rated Quality of Life (EQ-5D)
Time Frame: 12 months
EQ-5D is an instrument which evaluates the generic quality of life. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The options are in 5-step scale. The EQ-5D questionnaire also includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 24, 2022

Primary Completion (Estimated)

January 31, 2025

Study Completion (Estimated)

January 31, 2026

Study Registration Dates

First Submitted

April 9, 2024

First Submitted That Met QC Criteria

April 9, 2024

First Posted (Actual)

April 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 31, 2024

Last Update Submitted That Met QC Criteria

October 29, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HUS/206/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Public access to the final trial dataset will be available on reasonable request from the principal investigator for research purposes

IPD Sharing Time Frame

10 years

IPD Sharing Access Criteria

Public access to the final trial dataset will be available on reasonable request from the principal investigator for research purposes. Study protocol, SAP and ICF will be pupblished as a part of the study protocol

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Telerehabilitation

Subscribe